Join to access to all OVN content. Join for Free
It Can be Lonely in the Life of an MSL
Medical Science Liaison MSL mentorship KOL engagement professional development work-life balance

It Can be Lonely in the Life of an MSL


Share This Article


Summary

In this episode, Tom Caravela welcomes special guest Trish Gorecki to share her insights and experiences as a Medical Science Liaison (MSL). The conversation delves into overcoming challenges and frustrations in the MSL role, emphasizing the importance of mentorship and networking. Trish discusses coping strategies for isolation, handling setbacks, and improving Key Opinion Leader (KOL) engagement. The episode provides a comprehensive look at burnout, work-life balance, and effective time management, especially during travel. Trish highlights essential resources and tools for MSLs, stressing the significance of continuous personal and professional development. The episode concludes with final advice for both current and aspiring MSLs.

Key Points

  • Building and maintaining strong internal and external networks is crucial for overcoming the challenges and isolation often experienced by MSLs in the field.
  • Persistence and strategic relationship-building are key to gaining access to KOLs, especially in a competitive and evolving market landscape.
  • Taking personal responsibility for professional development through available resources, mentorship, and continuous learning can significantly enhance the effectiveness and satisfaction of MSLs.

Click for Source
Medical Science Liaison, MSL mentorship, KOL engagement, professional development, work-life balance

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN